Floatz logo

Eloxatin

Breast

University of Southern CaliforniaPhase 2/3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Breast cohort.

Asset / SponsorPhaseRating
Vinorelbine
Sun Yat-sen University
Phase 2BB
Olaparib
AstraZeneca
Phase 2BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Beni-Suef University
Phase 2B
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Beni-Suef University
Phase 2B
Pycnogenol
National Center for Complementary and Integrative Health (NCCIH)
Phase 2B

View all 14 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →